1XDA image
Entry Detail
PDB ID:
1XDA
Keywords:
Title:
STRUCTURE OF INSULIN
Biological Source:
Source Organism:
PDB Version:
Deposition Date:
1996-12-18
Release Date:
1997-07-07
Method Details:
Experimental Method:
Resolution:
1.80 Å
R-Value Work:
0.17
Space Group:
H 3
Macromolecular Entities
Polymer Type:polypeptide(L)
Description:FATTY ACID ACYLATED INSULIN
Chain IDs:A, C, E, G
Chain Length:21
Number of Molecules:4
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Description:FATTY ACID ACYLATED INSULIN
Chain IDs:B, D, F, H
Chain Length:29
Number of Molecules:4
Biological Source:Homo sapiens
Primary Citation
Crystal structure of a prolonged-acting insulin with albumin-binding properties.
Biochemistry 36 2826 2831 (1997)
PMID: 9062110 DOI: 10.1021/bi9625105

Abstact

The fatty acid acylated insulin, Lys(B29)-tetradecanoyl, des-(B30) human insulin, has been crystallized and the structure determined by X-ray crystallography. The fatty acid substituent on residue B29 Lys binds reversibly to circulating albumin protein in vivo, and by this mechanism the hormone's action is prolonged. Crystals of the fatty acid insulin grow in space group R3, with two dimers in the asymmetric unit, and diffract to 1.8 A spacing. The structure has been solved by molecular replacement and refined using a maximum likelihood method. The crystal structure consists of R6 zinc insulin hexamers which contain phenol. The fatty acids can be seen bound between the hexamers, making specific interactions with the side chains of residue B1 Phe; however, the lysine side chains to which the fatty acids are covalently attached are mostly disordered. The mode of binding of the fatty acids appears to be determined by crystal packing, and whether or not they interact with the protein in this way in solution remains uncertain.

Legend

Protein

Chemical

Disease

Primary Citation of related structures